Publications by authors named "Amber Zhang"
Introduction: Belimumab is a recombinant human immunoglobulin G1λ monoclonal antibody indicated as an intravenous (IV) 10 mg/kg and subcutaneous (SC) 200-mg dose for the treatment of systemic lupus erythematosus (SLE). Belimumab 10 mg/kg IV has been approved for the treatment of patients with SLE in China. This phase 1 study investigated the pharmacokinetics (PK), safety, and tolerability of belimumab 200 mg SC and the approved IV formulation in a healthy Chinese population.
View Article and Find Full Text PDFArticle Synopsis
- Vertebral labelling and segmentation are crucial for improving automated spine image processing, aiding in clinical decision-making and population health analysis.
- The Large Scale Vertebrae Segmentation Challenge (VerSe) was created to tackle the challenges of this field by having participants develop algorithms for labelling and segmenting vertebrae using a curated dataset of CT scans.
- Results showed that an algorithm's performance depends significantly on its ability to identify vertebrae with rare anatomical variations, highlighting the complexities in spine analysis.